Omnicare (OCR) Reports In-Line Q2 EPS

Omnicare (NYSE: OCR) reported Q2 EPS of $1.02, in-line with the analyst estimate of $1.02. Revenue for the quarter came in at $1.7 billion versus the consensus estimate of $1.68 billion.

For earnings history and earnings-related data on Omnicare (OCR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c